Despite Research Breakthroughs, an Anti-Aging Pill Is Still a Long Way Off

July 28, 2015

(The Conversation) – Last month a team of doctors and scientists made the case to regulators at the Food and Drug Administration (FDA) to consider approving anti-aging drugs as a new pharmaceutical class. Such a designation would treat aging as disease rather than a natural process, potentially opening the door to government funding for anti-aging drug trials.